Methods for assessing binding of a small-molecule radioligand to soluble enzyme isocitrate dehydrogenase 1 variants. (PubMed, EJNMMI Radiopharm Chem) - Sep 23, 2026 - "The findings support the use of radioligand-based approaches for characterizing soluble intracellular protein targets, while highlighting the need for assay-specific optimization and careful interpretation of quantitative binding parameters."
Journal • Brain Cancer • Glioma • Oncology • Solid Tumor • IDH1
|
|
Andreas Maurer; Barbara Wenzel; Thu Hang Lai; Winnie Deuther-Conrad
|